O'Neill Institute  |  February 28, 2024

Read the Publication

Doxycycline, a commonly prescribed antibiotic that has been in use for more than fifty years, has recently been shown to be useful in preventing the bacterial sexually transmitted infections (STIs) chlamydia, gonorrhea, and syphilis. This offers a new tool for preventing STIs when administered as post-exposure prophylaxis (PEP). How this new intervention is integrated into practice is critically important and calls for new approaches to prevention.

Read the Big Ideas in Brief here.

Issues

HIV/AIDS

Latest publications See All

Report

October 14, 2025

Charles Holmes Maggie Little, Ph.D.; Heidi Weimer, J.D., MPH, LL.M; Dylan Green, MPH; Alicia Patterson, Ph.D.; Jonathan Healey; Sydney Luken; Janet Tatenda Bhila; Aleny Couto, MD; Shona Dalal, PhD; Will Fleisher, PhD; Jen Gennai; Rayid Ghani; Peter Godfrey-Faussett; Melissa Goldstein, JD; Kathy Hageman, PhD, MPH; Nina Hasen, PhD; Micheal Ighodaro; Thoko Kalua, MBBS, MSc; Jennifer Miller, PhD; Yogan Pillay, PhD; Anton Pozniak, MD; Miriam Rabkin, MD, MPH; David Ribes, PhD; Lisa Singh, PhD